(PharmaNewsWire.Com, December 22, 2017 ) According to the report Liquid Biopsy, published by Market Data Forecast, the Latin America market is projected to reach USD 942 billion by 2021, at a CAGR of 12.05% from 2016 to 2021.
Head and Neck cancer is one of the most prevalent and a common type of cancer worldwide. As the root cause of many of these cancers are the higher intake of tobacco and alcohol, it is most prevalent in those regions where the consumption is high. Detection of cancer in early stages and appropriate treatment offer the best possible cure for these diseases. The primary reason for the growth in the market is attributed to the increasing number of diagnostic procedures for head and neck cancer, particularly the procedures for the diagnosis of pharyngeal and oral cancers.
Liquid Biopsy market in this region is primarily driven by factors like rising consumption of tobacco and alcohol in this region. Hence the number of diagnostic procedures for this market are increasing. Detecting these cancers in the early stages helps a lot in treating these diseases.
There is an increased prevalence of chronic diseases due to rise in aging population, especially cancers relating to head and neck, increasing awareness among the individuals towards cancer. This results in rise in the healthcare expenditure of government. However, low adoption rate of digital technology based systems, conventional CT and MRI scanners, excise duty imposed on sale of Medical Devices in mature markets.
Latin America Liquid Biopsy: Region-wise Outlook
The market for Liquid Biopsy in Latin America region is divided based on geography into Brazil, Argentina, Chile, Peru and other parts in the region. With an increase in demand for diagnostic imaging, incorporating novel technologies in diagnostic instruments and advances in treatment modes, it is expected that market growth is going to propel during the forecast period.
Key Questions Answered
What is the current and future Liquid Biopsy outlook in Latin America market? What trends are affecting the Latin America market?
What is the competitive landscape and market share of major players in the Liquid Biopsy space in Latin America market?
What are the key, high growth markets that Liquid Biopsy manufacturers should expand into? Which market segments are growing the fastest?
What are the unmet needs with the Liquid Biopsy currently on the market? How will emerging technologies fulfil these unmet needs?
What is physician perception and market outlook of Liquid Biopsy?
What are the challenges and barriers that have hindered widespread adoption of Liquid Biopsy?
Latin America Liquid Biopsy: Key Players
Some of the key players influencing the market dynamics Philips Healthcare, Siemens Healthcare, Varian Medical Systems, Shimadzu Corporation, GE Healthcare, Shimadzu Corporation, Identafi, Velscope VX, AdDent Inc.
Reasons to buy Latin America Liquid Biopsy Report:
Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Latin America Healthcare Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
